These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 24394006)

  • 1. [Lymph node metastasis of colorectal cancer with submucosal invasion].
    Yatsuoka T; Nishimura Y; Sakamoto H; Tanaka Y; Kurozumi M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2041-3. PubMed ID: 24394006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of recurrence in high-risk T1 colon cancer following endoscopic and surgical resection: registry-based cohort study.
    Nilsson E; Wetterholm E; Syk I; Thorlacius H; Rönnow CF
    BJS Open; 2024 May; 8(3):. PubMed ID: 38869239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of lymph node metastasis in patients with pedunculated type early invasive colorectal cancer: a retrospective multicenter study.
    Matsuda T; Fukuzawa M; Uraoka T; Nishi M; Yamaguchi Y; Kobayashi N; Ikematsu H; Saito Y; Nakajima T; Fujii T; Murakami Y; Shimoda T; Kushima R; Fujimori T
    Cancer Sci; 2011 Sep; 102(9):1693-7. PubMed ID: 21627735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches and considerations in the endoscopic treatment of T1 colorectal cancer.
    Jung Y
    Korean J Intern Med; 2024 Jul; 39(4):563-576. PubMed ID: 38742279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations of pathomorphological parameters between lesions at the invasive front and lymph node metastases in colorectal cancer: a retrospective clinical study.
    Peng H; Zhang Z; Wu Y; Zhu Y
    J Egypt Natl Canc Inst; 2024 Jul; 36(1):23. PubMed ID: 38945978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the artificial intelligence in the management of T1 colorectal cancer.
    Ichimasa K; Kudo SE; Misawa M; Takashina Y; Yeoh KG; Miyachi H
    Dig Liver Dis; 2024 Jul; 56(7):1144-1147. PubMed ID: 38311532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curative criteria for endoscopic treatment of colorectal cancer.
    Quénéhervé L; Pioche M; Jacques J
    Best Pract Res Clin Gastroenterol; 2024 Feb; 68():101883. PubMed ID: 38522881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of vertical margin involvement in endoscopic resection for T1 colorectal cancer.
    Kano Y; Yamamoto Y; Ikematsu H; Sasabe M; Minakata N; Watanabe T; Yamashita H; Mitsui T; Inaba A; Sunakawa H; Nakajo K; Murano T; Kadota T; Shinmura K; Yano T
    Dig Endosc; 2024 Apr; 36(4):455-462. PubMed ID: 37572330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in Implementing Endoscopic Resection for T2 Colorectal Cancer.
    Ichimasa K; Kudo SE; Tan KK; Lee JWJ; Yeoh KG
    Gut Liver; 2024 Mar; 18(2):218-221. PubMed ID: 37842729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of non-curative endoscopic resection of T1 colon cancer.
    Bernklev L; Nilsen JA; Augestad KM; Holme Ø; Pilonis ND
    Best Pract Res Clin Gastroenterol; 2024 Feb; 68():101891. PubMed ID: 38522886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local massive venous invasion in colorectal cancer: CT-pathological correlation and its clinical implication.
    Nakajima I; Aoki J; Sakurai S; Naitoh H; Taketomi-Takahashi A; Tsushima Y
    Br J Radiol; 2015 Jan; 88(1045):20140319. PubMed ID: 25353693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Does Omitting Additional Surgery After Local Excision Affect the Prognostic Outcome of Patients With High-risk T1 Colorectal Cancer?
    Ouchi A; Komori K; Masahiro T; Toriyama K; Kajiwara Y; Oka S; Fukunaga Y; Hotta K; Ikematsu H; Tsukamoto S; Nagata S; Yamada K; Konno M; Ishihara S; Saitoh Y; Matsuda K; Togashi K; Ishiguro M; Kuwai T; Okuyama T; Ohuchi A; Ohnuma S; Sakamoto K; Sugai T; Katsumata K; Matsushita HO; Nakai K; Uraoka T; Akimoto N; Kobayashi H; Ajioka Y; Sugihara K; Ueno H;
    Ann Surg; 2024 Feb; 279(2):290-296. PubMed ID: 37669045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Location as a Prognostic Factor in T1 Colorectal Cancer.
    Ichimasa K; Kudo SE; Kouyama Y; Mochizuki K; Takashina Y; Misawa M; Mori Y; Hayashi T; Wakamura K; Miyachi H
    J Anus Rectum Colon; 2022; 6(1):9-15. PubMed ID: 35128132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Decision for Locally Resected T1 Colorectal Carcinoma-Verification of the Japanese Guideline Criteria for Additional Surgery Based on Long-Term Clinical Outcomes.
    Oka S; Tanaka S; Kajiwara Y; Saito S; Fukunaga Y; Takamatsu M; Kawachi H; Hotta K; Ikematsu H; Kojima M; Saito Y; Yamada M; Kanemitsu Y; Sekine S; Nagata S; Yamada K; Kobayashi N; Ishihara S; Saitoh Y; Matsuda K; Togashi K; Komori K; Ishiguro M; Kuwai T; Okuyama T; Ohuchi A; Ohnuma S; Sakamoto K; Sugai T; Katsumata K; Matsushita HO; Yamano HO; Eda H; Uraoka T; Akimoto N; Kobayashi H; Sugihara K; Ueno H
    Am J Gastroenterol; 2024 Mar; ():. PubMed ID: 38345215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1 colorectal cancer management in the era of minimally invasive endoscopic resection.
    Jiang SX; Zarrin A; Shahidi N
    World J Gastrointest Oncol; 2024 Jun; 16(6):2284-2294. PubMed ID: 38994167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the guidelines for colorectal cancer in Japan, the USA and Europe.
    Shinagawa T; Tanaka T; Nozawa H; Emoto S; Murono K; Kaneko M; Sasaki K; Otani K; Nishikawa T; Hata K; Kawai K; Watanabe T
    Ann Gastroenterol Surg; 2018 Jan; 2(1):6-12. PubMed ID: 29863118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway.
    Su W; Feng B; Hu L; Guo X; Yu M
    BMC Cancer; 2022 Jun; 22(1):602. PubMed ID: 35655161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated NTF4 in colorectal cancer promotes tumor development via regulating autophagy.
    Yang Z; Chen Y; Wei X; Wu D; Min Z; Quan Y
    Int J Oncol; 2020 Jun; 56(6):1442-1454. PubMed ID: 32236587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of risk factors for colon cancer progression.
    Yang Z; Chen Y; Wu D; Min Z; Quan Y
    Onco Targets Ther; 2019; 12():3991-4000. PubMed ID: 31190895
    [No Abstract]   [Full Text] [Related]  

  • 20. Andrographolide enhanced 5-fluorouracil-induced antitumor effect in colorectal cancer via inhibition of c-MET pathway.
    Su M; Qin B; Liu F; Chen Y; Zhang R
    Drug Des Devel Ther; 2017; 11():3333-3341. PubMed ID: 29200829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.